DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
78.92
+4.62 (6.22%)
At close: Sep 3, 2025, 4:00 PM
78.95
+0.03 (0.04%)
After-hours: Sep 3, 2025, 4:00 PM EDT
DexCom Employees
DexCom had 10,300 employees as of December 31, 2024. The number of employees increased by 700 or 7.29% compared to the previous year.
Employees
10,300
Change (1Y)
700
Growth (1Y)
7.29%
Revenue / Employee
$417,553
Profits / Employee
$55,485
Market Cap
30.95B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10,300 | 700 | 7.29% |
Dec 31, 2023 | 9,600 | 2,000 | 26.32% |
Dec 31, 2022 | 7,600 | 600 | 8.57% |
Dec 31, 2021 | 7,000 | 600 | 9.38% |
Dec 31, 2020 | 6,400 | 1,200 | 23.08% |
Dec 31, 2019 | 5,200 | 1,300 | 33.33% |
Dec 31, 2018 | 3,900 | 910 | 30.43% |
Dec 31, 2017 | 2,990 | 690 | 30.00% |
Dec 31, 2016 | 2,300 | 791 | 52.42% |
Dec 31, 2015 | 1,509 | 448 | 42.22% |
Dec 31, 2014 | 1,061 | 296 | 38.69% |
Dec 31, 2013 | 765 | 67 | 9.60% |
Dec 31, 2012 | 698 | 78 | 12.58% |
Dec 31, 2011 | 620 | 100 | 19.23% |
Dec 31, 2010 | 520 | 135 | 35.06% |
Dec 31, 2009 | 385 | 81 | 26.64% |
Dec 31, 2008 | 304 | 52 | 20.63% |
Dec 31, 2007 | 252 | -8 | -3.08% |
Dec 31, 2006 | 260 | 105 | 67.74% |
Dec 31, 2005 | 155 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
DXCM News
- 6 days ago - DexCom, GE, SLB: Why Experts Rate These Stocks at Strong Buy - Kiplinger
- 8 days ago - Dexcom Announces Upcoming Conference Presentations - Business Wire
- 4 weeks ago - 10 stocks favored to gain up to 30% in a sector that has missed this year's rally - Market Watch
- 4 weeks ago - DexCom, Inc. (DXCM) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Dexcom beats estimates for quarterly results, names new CEO - Reuters
- 5 weeks ago - Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan - Business Wire
- 5 weeks ago - Ontario Expands Access to Dexcom G7 CGM Under the Ontario Drug Benefit (ODB) Program - Business Wire
- 5 weeks ago - Dexcom Launches Revolutionary AI-Powered Meal Logging Feature Across Glucose Biosensing Portfolio - Business Wire